endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news

Financing channel feed

Third Rock can­cer start­up Rev­o­lu­tion Med­i­cines scores $100M in fresh raise

6 years ago

Trade ten­sions are im­ped­ing the flow of Chi­nese mon­ey to US biotechs — but how much?

6 years ago
China

ADC Ther­a­peu­tics has raised $550M-plus in its quest for their first BLA — and here’s why that’s im­por­tant

6 years ago

Ger­man can­cer biotech BioN­Tech rais­es a mam­moth $325M in lat­est round, bring­ing to­tal haul to $1.4B+

6 years ago

IGM Bio­sciences banks a $103M megaround on its quest to pi­o­neer a new kind of can­cer-fight­ing an­ti­body

6 years ago

Medicxi, Tai­ho in­fuse €30M in­to Evotec spin­out — eye­ing can­cer meds tar­get­ing DNA dam­age re­sponse path­ways

6 years ago
Startups

SV joins CRUK on a $250M-plus fund with an eye on de­vel­op­ing new can­cer drugs

6 years ago

In­vestors trapped for an­oth­er 28 days as sus­pen­sion of Wood­ford flag­ship fund drags on

6 years ago
People

Bay­er, Ver­sant back a $250M cell ther­a­py start­up on a quest to cre­ate off-the-shelf im­muno-on­col­o­gy ther­a­pies

6 years ago
Cell/Gene Tx

Neil Wood­ford re­fresh­es port­fo­lio with fire sale while in­vestors pon­der fu­ture of sus­pend­ed fund

6 years ago
People

Puretech-backed Karuna makes Nas­daq de­but with $89M IPO

6 years ago

Tar­get­ing tox­ic pro­tein ag­gre­ga­tion, Ger­man biotech banks €12M to de­vel­op drug for rare neu­rode­gen­er­a­tive dis­or­der

6 years ago
Startups

Bridge­Bio takes crown for biggest biotech IPO of 2019, as fel­low uni­corn Adap­tive rais­es of­fer­ing size and price

6 years ago

Vesal­ius gets to work on €120M Fund III — ex­pect more on wom­en's health, on­col­o­gy

6 years ago

Af­ter rais­ing $158M, this up­start's founders have star back­ers and plans to break new ground in gene ther­a­py

6 years ago
Startups
Cell/Gene Tx

Rare dis­ease play­er rakes in a meaty $81M in Spain's biggest ever pri­vate biotech fundraise

6 years ago

Chris Var­ma un­veils MP­M's lat­est start­up — eye­ing 'un­drug­gable' can­cer tar­gets and pow­ered by ma­chine learn­ing, $67M

6 years ago
Startups

Tasly Bio­phar­ma pitch­es long-await­ed IPO — will it trig­ger an­oth­er $1B gold rush on HKEX?

6 years ago
China

With 4 more biotech IPOs due to wrap up Q2, how is the class of 2019 far­ing?

6 years ago

In $86M IPO pitch, Mirum spells out plans to turn Shire dis­cards in­to or­phan liv­er drug suc­cess­es

6 years ago

Eli Cas­din backs Codex­is' plat­form tech with $50M eq­ui­ty buy

6 years ago
People

In­vestors pony up $476M for the lat­est round of biotech IPOs to hit the Street

6 years ago

Wood­ford braces po­lit­i­cal storm as UK fi­nan­cial reg­u­la­tors scru­ti­nize fund sus­pen­sion

6 years ago
People

Bob Langer's first port of call — Po­laris Part­ners — maps $400M for ninth fund

6 years ago
First page Previous page 110111112113114115116 Next page Last page
A service from the Financial Times